These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


237 related items for PubMed ID: 1349341

  • 1. Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease.
    Pifl C, Nanoff C, Schingnitz G, Schütz W, Hornykiewicz O.
    J Neurochem; 1992 Jun; 58(6):1997-2004. PubMed ID: 1349341
    [Abstract] [Full Text] [Related]

  • 2. Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.
    Pifl C, Reither H, Hornykiewicz O.
    Eur J Pharmacol; 1991 Sep 17; 202(2):273-6. PubMed ID: 1839386
    [Abstract] [Full Text] [Related]

  • 3. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.
    Pifl C, Schingnitz G, Hornykiewicz O.
    Neuroscience; 1991 Sep 17; 44(3):591-605. PubMed ID: 1754053
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
    Morissette M, Grondin R, Goulet M, Bédard PJ, Di Paolo T.
    J Neurochem; 1999 Feb 17; 72(2):682-92. PubMed ID: 9930741
    [Abstract] [Full Text] [Related]

  • 5. Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat.
    Pifl C, Reither H, Hornykiewicz O.
    Brain Res; 1992 Feb 14; 572(1-2):87-93. PubMed ID: 1535275
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T.
    Synapse; 1999 Jun 01; 32(3):153-64. PubMed ID: 10340626
    [Abstract] [Full Text] [Related]

  • 16. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
    Morissette M, Goulet M, Calon F, Falardeau P, Blanchet PJ, Bédard PJ, Di Paolo T.
    Mol Pharmacol; 1996 Nov 01; 50(5):1073-9. PubMed ID: 8913337
    [Abstract] [Full Text] [Related]

  • 17. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M, Morin N, Grégoire L, Rajput A, Rajput AH, Di Paolo T.
    Biochem Pharmacol; 2016 Jun 01; 109():62-69. PubMed ID: 27038656
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease.
    Pifl C, Schingnitz G, Hornykiewicz O.
    Neurosci Lett; 1988 Oct 05; 92(2):228-33. PubMed ID: 3263594
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.